Discovery & Development

With new drugs showing promise for Alzheimer’s, is the drug development drought over?

Sitting Down With… Sharon L Rogers, AmyriAD CEO, Renowned drug developer, 2023 Power Lister, and Olympic figure skating official

In the second episode of the We Salute You series, we focus on much maligned Hungarian physician Ignaz Semmelweis

Why one company is focusing on camelid-derived antibodies to tackle dengue.

Studying the link between Alzheimer’s risk, estrogen levels, and menopausal status in women

Perrigo’s Opill receives FDA approval following unanimous support from advisory committees

How scientists extracted a treatment for episodic ataxia from traditional Kwakwaka'wakw medicine

We need non-opioid options for pain relief. Paradigm Biopharmaceuticals discuss their studies into a new option for osteoarthritis patients

Researchers demonstrate that microRNA-132 can significantly affect different brain cells, with potential implications for Alzheimer’s disease.

TUM Researchers create organoid that emulates the development of the human heart